This body of research collectively advances the understanding and application of CRISPR technology, emphasizing its versatility and transformative potential in genetic engineering. Shalem et al. (2014) demonstrated the power of CRISPR-Cas9 for genome-scale knockout screening in human cells, highlighting its utility in identifying gene functions. Qi et al. (2013) explored the repurposing of CRISPR as an RNA-guided tool for precise gene expression modulation, expanding CRISPR's applications beyond genetic editing to gene regulation. Zetsche et al. (2015) introduced Cpf1 (now known as Cas12a) as a distinct CRISPR enzyme with unique features, such as a smaller guide RNA requirement and sticky-end DNA cuts, broadening the toolkit available for genomic editing. Chen et al. (2018) revealed Cas12a's unique property of indiscriminate ssDNA cleavage upon target binding, which has implications for developing sensitive diagnostic tools. These studies collectively underscore CRISPR's flexibility while also identifying new avenues for research and application, from basic biological research to innovative therapeutic and diagnostic approaches.

🎓 Deep dive with Scholar iON →